PEPperPRINT
Private Company
Total funding raised: $6M
Overview
PEPperPRINT is a privately held, revenue-generating platform and services company specializing in high-density peptide microarray technology. Its proprietary laser-printing technology enables the combinatorial synthesis of highly overlapping peptide libraries on microarrays, allowing for high-resolution, high-throughput analysis of linear and conformational epitopes. The company serves research and diagnostic needs in immunology, infectious disease, and antibody development, providing critical tools for characterizing immune responses. PEPperPRINT operates from its headquarters in Heidelberg, Germany, leveraging its strong IP position and scientific expertise.
Technology Platform
Proprietary combinatorial synthesis of high-density peptide microarrays using amino acid toner particles and a custom 24-color laser printer. Enables production of highly overlapping peptide libraries for high-resolution, high-throughput epitope mapping and antibody profiling.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
PEPperPRINT competes with providers of traditional epitope mapping services (e.g., ELISA-based, SPOT synthesis) and other peptide array technologies. Its key differentiators are the ability to map conformational epitopes, single-amino-acid resolution, high throughput, and lower sample requirements. It faces competition from larger proteomics and life science tools companies that may offer broader but less specialized platforms.